Darunavir Intermedia CAS 102123-74-0 Puritas ≥98.0% (HPLC)
| Nomen chemicum | (3S) -3-(tert-Butoxycarbonyl) amino-1-Chloro-4-Phenyl-2-Butanone |
| Synonyma | (S)-tert-Butyl (4-Chloro-3-oxo-1-Phenylbutan-2-yl) Carbamate |
| CAS Number | 102123-74-0 |
| CATTUS Number | RF-PI287 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C15H20ClNO3 |
| M. Pondus | 297.78 |
| Shipping Condition | Uit sub Ambient Temperature |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White Crystalline pulveris |
| Lepidium sativum (HPLC) | Lepidium sativum confirmatur HPLC |
| Damnum in Siccatio | ≤0.50% |
| Humor (KF) | ≤0.50% |
| Liquescens punctum | 104.0~ 107.0℃ |
| Residere in Ignition | ≤0.20% |
| Imprimis Rotationes | -48.0° ~ -42.0° |
| Puritas / Analysis Methodus | ≥98.0% (HPLC) |
| Test Standard | Enterprise Standard |
| Consuetudinem | Darunavir (CAS 206361-99-1) HIV-1 Protease Inhibitor |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum (3S)-3-(tert-Butoxycarbonyl) amino-1-Chloro-4-Phenyl-2-Butanone (CAS: 102123-74-0) qualitatis, medium typice in synthesi Darunavir (CAS 206361-99-1) et Darunavir Ethanolate (CAS 635728-49-3).
Darunavir (CAS 206361-99-1) (TMC114) est secunda generatio inhibitor nonpeptidica HIV protease, AIDS et HIV infectio tractandi usus est, structurae similis amprenavir.Antiviral.Ob resistentiam medicamentorum Antiviralium cum sola adhibita cessum, administratur cum aliis agentibus Anti-HIV.Darunavir inhibitor oraliter bioavailable non-peptidicus est generis virus immuno- rum humanorum 1 (HIV-1) protease quae selective vetat HIV-1 protease enzyma inducta synthesis gag et gag-pol poly-prohibens maturationem virionum et etiam vetat. dimerizationem HIV-1 activitatis protease suppressionis proteolyticae et replicationis subsequentis HIV-1.
